Plasma methylmalonic acid predicts risk of acute myocardial infarction and mortality in patients with coronary heart disease: A prospective 2-cohort study.
Indu DharVegard LysneArve UlvikGard F T SvingenEva R PedersenEspen Ø BjørnestadThomas OlsenRobert BorsholmJohnny Laupsa-BorgePer M UelandGrethe S TellRolf K BergeGunnar MellgrenKaare H BønaaOttar K NygårdPublished in: Journal of internal medicine (2023)
Elevated MMA was associated with an increased risk of AMI and mortality in patients with suspected or verified CHD. This article is protected by copyright. All rights reserved.